MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  
HCP Resources  Psychiatry  

Patient Resources 
Bipolar  
Diabetes  
Schizophrenia  


Useful Websites

specialistinfo.com
details of 26,000 UK specialists

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

DoctorOnline
information for doctors

The Converter Site
metric and imperial conversion tool.
home > drug information > PLAVIX

PLAVIX


Company: Sanofi, Bristol-Myers Squibb
Approval Status: Approved November 1997
Treatment for: atherosclerosis
Areas: Cardiology/Vascular Diseases; Endocrinology
Possible similar drugs: Plavix

| General Information | Clinical Results | Side Effects |


General Information

Other Useful Resources

PLAVIX (clopidogrel bisulfate) has been approved for the reduction of atherosclerotic events (myocardial infaraction, stroke, vascular deaths) in patients with atherosclerosis documented by recent myocardial infarctions, recent stroke, or established peripheral arterial disease.



< back to top

Clinical Results

The clearance to market PLAVIX was based primarily on the results of the CAPRIE clinical trial, a randomized, double-blind trial that enrolled 19,185 patients who had suffered a recent ischemic stroke, recent heart attack, or had established peripheral arterial disease.

CAPRIE compared the efficacy and safety of clopidogrel and aspirin in reducing subsequent strokes, heart attacks, and other vascular events in patients treated for a period of one to three years.



< back to top

Side Effects

PLAVIX is contraindicated in patients with active pathologic bleeding or who have shown hypersensitivity to the drug or any component of the drug and should be used with caution in patients with severe liver disease. The most frequent side effects are rash, diarrhea, and pruritis.



< back to top



The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.






pda medical dictionary
pda software - $15

PDA Medical Dictionary

only $15

Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

>> Click here for more on the PDA Medical Dictionary <<





Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, Mexico Office: + 52 1998 2142733
© 2007 MediLexicon International Ltd. MediLexicon International Ltd